Healthcare News

CAMBRIDGE, Mass., March 17, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that it will be...

Oral Hammaslääkärit Oyj Pörssitiedote 17.3.2009 klo 11.10 ORALIN TILINPÄÄTÖS JA TIEDOTTEIDEN VUOSIKOOSTE JULKAISTU Oral Hammaslääkärit Oyj:n vuosikertomus, joka sisältää konsernin ja...

WALTHAM, Mass., March 17, 2009 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (XSSE:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases,...

WALTHAM, Mass., March 17, 2009 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (XSSE:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye...

SAN DIEGO, March 16, 2009 (GLOBE NEWSWIRE) -- OccuLogix, Inc. dba TearLab Corporation (Nasdaq:TEAR) (TSX:TLB) today announced that Benjamin Sullivan, PhD, Chief Scientific Officer for the Company, is...

CEDAR KNOLLS, N.J., March 16, 2009 (GLOBE NEWSWIRE) -- Emisphere Technologies, Inc. (Nasdaq:EMIS) a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules...

WIXOM, Mich., March 16, 2009 (GLOBE NEWSWIRE) -- Rockwell Medical Technologies, Inc. (Nasdaq:RMTI), a fully-integrated biopharmaceutical company offering innovative products and services targeting...

PHILADELPHIA, March 16, 2009 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE Alternext US:HEB) announced its financial results for the fiscal year ended December 31, 2008. The net loss for the...

BERKELEY, Calif., March 16, 2009 (GLOBE NEWSWIRE) -- XOMA Ltd. (Nasdaq:XOMA), a leader in the discovery and development of antibody therapeutics, announced today that Steven Engle, Chairman and Chief...

MEDDELELSE NR. 33 16. marts 2009 Indberetning af insideres handel med ChemoMetec-aktier I henhold til værdipapirhandelslovens § 28a skal ChemoMetec A/S indberette oplysninger om ledende...